CompoAtlas

NMN 21000

Natural health product licensed in Canada

Other names
Rejuve NMN 21000, Rejuve NMN 350mg, RejuveMe 21000
Licence holder
OCHK International Trading Co.Ltd. DBA Rejuve Health Products
NPN or DIN-HM
80132725
Status
Active licence
Licence date
23 July 2024
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of Vitamin B3 to help in metabolism and tissue formation. Helps to increase NAD+ level, a cofactor in cellular energy metabolism. Helps to increase the level of NAD+, an essential to maintain a healthy metabolism. Helps to improve physical performance in a low-resistance, short-duration exercise (such as walking) in middle-aged adults. NMN is a NAD+ precursor which plays a key role in the maintenance of general health. Source of Vitamin B3 to support biological functions which play a key role in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80132725

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line